Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int J Nanomedicine. 2012;7:1079-89. doi: 10.2147/IJN.S29183. Epub 2012 Feb 22.

Mannosylated liposomes for targeted gene delivery.

Author information

  • 1Department of Hematology, General Hospital of Ji'nan Command, PLA, Ji'nan, People's Republic of China.

Abstract

BACKGROUND:

Liposomes can be modified with different ligands to control their biological properties, such as longevity, targeting ability, and intracellular penetration, in a desired fashion. The aim of this study was to modify liposomes with a novel mannosylated polyethylene glycol-phosphatidylethanolamine (M-PEG-PE) ligand to achieve active targeted gene delivery.

METHODS:

Rat Kupffer cells were isolated and used as model cells for in vitro evaluation of cytotoxicity and transfection efficiency. The modified liposomes were intravenously injected into the rats, and Kupffer cells were isolated and analyzed by flow cytometry for in vivo gene delivery and expression.

RESULTS:

The M-PEG-PE-modified liposome-enhanced green fluorescence protein plasmid (M-PEG-PE-Lipo-pEGFP) complexes had a particle size of 237 nm and a loading efficiency of 90%. The M-PEG-PE-Lipo-pEGFP complexes displayed remarkably higher transfection efficiency than unmodified Lipo-pEGFP, both in vitro (51%-30%) and in vivo (43%-27%).

CONCLUSION:

M-PEG-PE could function as an excellent active targeting ligand, and M-PEG-PE-modified liposomes could be promising active targeted drug delivery vectors.

KEYWORDS:

active targeting; gene delivery; liposomes; mannosylated; phosphatidyle-thanolamine; polyethylene glycol

PMID:
22393297
[PubMed - indexed for MEDLINE]
PMCID:
PMC3289440
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Dove Medical Press Icon for PubMed Central
    Loading ...
    Write to the Help Desk